Statistical optimisation of diclofenac sustained release pellets coated with polymethacrylic films

被引:84
作者
Kramar, A [1 ]
Turk, S [1 ]
Vrecer, F [1 ]
机构
[1] KRKA DD, R&D Div, Novo Mesto 8501, Slovenia
关键词
sustained release; pellet coating; Box-Behnken design; diclofenac sodium; Eudragit RS; Eudragit RL; dissolution;
D O I
10.1016/S0378-5173(03)00061-9
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The objective of the present study was to evaluate three formulation parameters for the application of polymethacrylic films from aqueous dispersions in order to obtain multiparticulate sustained release of diclofenac sodium. Film coating of pellet cores was performed in a laboratory fluid bed apparatus. The chosen independent variables, i.e. the concentration of plasticizer (triethyl citrate), methacrylate polymers ratio (Eudragit RS:Eudragit RL) and the quantity of coating dispersion were optimised with a three-factor, three-level Box-Behnken design. The chosen dependent variables were cumulative percentage values of diclofenac dissolved in 3, 4 and 6 h. Based on the experimental design, different diclofenac release profiles were obtained. Response surface plots were used to relate the dependent and the independent variables. The optimisation procedure generated an optimum of 40% release in 3 h. The levels of plasticizer concentration, quantity of coating dispersion and polymer to polymer ratio (Eudragit RS:Eudragit RL) were 25% w/w, 400 g and 3/1, respectively. The optimised formulation prepared according to computer-determined levels provided a release profile, which was close to the predicted values. We also studied thermal and surface characteristics of the polymethacrylic films to understand the influence of plasticizer concentration on the drug release from the pellets. (C) 2003 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:43 / 52
页数:10
相关论文
共 18 条
[1]  
Amighi K, 1996, EUR J PHARM BIOPHARM, V42, P29
[2]   Optimization of propranolol hydrochloride sustained-release pellets using Box-Behnken design and desirability function [J].
Bodea, A ;
Leucuta, SE .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1998, 24 (02) :145-155
[3]  
Daumesnil R, 1994, MULTIPARTICULATE ORA, P457
[4]  
FOLLONIER N, 1992, STP PHARMA SCI, V2, P141
[5]   INFLUENCE OF WATER-SOLUBLE AND INSOLUBLE PLASTICIZERS ON THE PHYSICAL AND MECHANICAL-PROPERTIES OF ACRYLIC RESIN COPOLYMERS [J].
GUTIERREZROCCA, JC ;
MCGINITY, JW .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1994, 103 (03) :293-301
[6]  
HARRIS MR, 1997, AQUEOUS POLYM COATIN, P81
[7]   Box-Behnken design for the optimization of formulation variables of indomethacin coprecipitates with polymer mixtures [J].
Karnachi, AA ;
Khan, MA .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1996, 131 (01) :9-17
[8]   Statistical optimization of Ketoprofen-Eudragit(R) S100 coprecipitates to obtain controlled-release tablets [J].
Khan, MA ;
Dib, J ;
Reddy, IK .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1996, 22 (02) :135-141
[9]  
LEHMANN K, 1989, PHARM PELLETIZATION, P51
[10]  
LEHMANN K, 1996, PRACTICAL COURSE FIL, P1